From: Safety and efficacy of G2-S16 dendrimer as microbicide in healthy human vaginal tissue explants
NT 1 | G2-S16 (3 mM) | N9 (4.5%) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epithelial injury | 1 | 1 | 2 | 2 | 0 | 2 | 2 | 2 | 1 | 2 | 2 | 0 | 2 | 1 | 1 | 2 | 1 | 2 | 4 | 4 | 3 | 4 | 4 |
Glandular cystic dilation | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inflammatory infiltrate | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 2 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 0 |
Hemorrhage | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Vascular proliferation | 0 | 2 | 2 | 0 | 0 | 1 | 2 | 2 | 1 | 1 | 2 | 1 | 1 | 0 | 2 | 1 | 1 | 0 | 3 | 4 | 4 | 3 | 4 |
Edema/fibrosis | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Necrosis | 1 | 2 | 1 | 0 | 0 | 1 | 0 | 2 | 0 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 0 | 1 | 3 | 4 | 3 | 3 | 4 |
Calcifications | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total score | 4 | 6 | 5 | 2 | 2 | 6 | 4 | 6 | 3 | 5 | 6 | 4 | 6 | 1 | 5 | 4 | 2 | 4 | 10 | 14 | 10 | 10 | 12 |